Medication info

Vibel Tablet 150 mg (Irbesartan)

Prescription medicationOralExpired
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White or nearly white, oval-shaped, biconvex tablet
Packaging
30 tablets/bottle
Approval status
Expired

MFDS item code 200703856 · Approved 2007.04.04

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of nephropathy in patients with hypertension and type 2 diabetes
Who takes it
Adults
Adult dose
Administration: This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of nephropathy in patients with hypertension and type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat essential hypertension and particularly helps prevent and treat kidney disease in patients with type 2 diabetes with hypertension. It effectively controls blood pressure and plays a role in delaying the deterioration of kidney function.

How to take

Adult dose

Administration: This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to it or its ingredients, if you are pregnant or breastfeeding, if you have severe liver dysfunction, or if you are a patient with hereditary angioedema. Caution is required for the elderly, patients with high potassium levels, patients with weakened liver function, patients with heart valve disease, or cardiovascular disease, as there is a risk of excessively low blood pressure or worsening kidney function. During the course of this medication, mild side effects such as dizziness, fatigue, headache, indigestion, and cough may occur, but most are temporary. Regular blood tests are necessary as potassium levels may increase, and kidney function may show abnormalities. Additionally, if symptoms of angioedema such as swelling of the face, lips, tongue occur, discontinue use immediately and consult a healthcare professional. This medication can interact with other blood pressure medications, diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), so inform your healthcare provider of any other medications you are taking. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding should be avoided during treatment, or breastfeeding should be discontinued. Safety in pediatric patients has not been established, so it should not be used in children. In case of overdose, symptoms such as hypotension or arrhythmia may occur, so if any symptoms present, seek medical attention immediately. This medication should be stored out of the reach of children, and transferring to another container should be avoided. Dizziness or fatigue may occur during treatment, so caution is needed when driving or operating machinery.

Side effects

  • Respiratory infections
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
Show 108 more
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmurs
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction disorder
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • myalgia
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • somnolence
  • emotional disorders
  • depression
  • sensory abnormalities
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • earache
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • weakness
  • nausea
  • tinnitus
  • hepatitis
  • liver function abnormalities
  • renal failure
  • psoriasis
  • photosensitivity reactions
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • rhabdomyolysis
  • sensory loss
  • hypertriglyceridemia
  • insomnia
  • dysgeusia
  • thirst
  • abdominal distension
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • surface changes
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a well-closed container to prevent exposure to air or moisture, and keep it in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White or nearly white, oval-shaped, biconvex tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.